IRIS UniCatt

Bellesi, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.256
EU - Europa 3.503
AS - Asia 3.312
SA - Sud America 608
AF - Africa 96
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.786
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.082
SG - Singapore 1.420
DE - Germania 1.067
CN - Cina 784
IT - Italia 535
SE - Svezia 510
BR - Brasile 492
VN - Vietnam 422
FR - Francia 317
PL - Polonia 224
GB - Regno Unito 194
FI - Finlandia 157
IN - India 128
UA - Ucraina 124
IE - Irlanda 112
CA - Canada 103
JP - Giappone 93
BD - Bangladesh 86
ID - Indonesia 83
RU - Federazione Russa 67
HK - Hong Kong 54
AR - Argentina 46
MX - Messico 44
NL - Olanda 35
TR - Turchia 33
AT - Austria 29
KR - Corea 28
IQ - Iraq 27
ZA - Sudafrica 23
TW - Taiwan 22
CI - Costa d'Avorio 21
CZ - Repubblica Ceca 21
BE - Belgio 20
SA - Arabia Saudita 16
ES - Italia 15
MA - Marocco 15
VE - Venezuela 15
EC - Ecuador 14
PK - Pakistan 14
IR - Iran 13
IL - Israele 12
UZ - Uzbekistan 11
CO - Colombia 10
CL - Cile 9
JO - Giordania 9
LT - Lituania 9
PH - Filippine 9
PY - Paraguay 9
CH - Svizzera 8
GR - Grecia 8
KE - Kenya 8
PT - Portogallo 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
HN - Honduras 6
MY - Malesia 6
RO - Romania 6
TN - Tunisia 6
JM - Giamaica 5
NP - Nepal 5
PE - Perù 5
AL - Albania 4
BG - Bulgaria 4
CR - Costa Rica 4
EE - Estonia 4
HU - Ungheria 4
KG - Kirghizistan 4
RS - Serbia 4
DK - Danimarca 3
ET - Etiopia 3
LB - Libano 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
KH - Cambogia 2
KZ - Kazakistan 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
Totale 11.771
Salva come PNG Salva come JPEG
Città #
Singapore 834
Chandler 482
Ashburn 431
San Jose 358
Warsaw 204
Munich 173
Beijing 163
New York 139
Ho Chi Minh City 123
The Dalles 121
Fairfield 116
Rome 111
Hanoi 110
Dublin 108
Los Angeles 106
Hefei 94
Jacksonville 91
Helsinki 90
Houston 90
San Mateo 81
Lauterbourg 75
Jakarta 74
Tokyo 73
Wilmington 65
Nanjing 64
Dallas 63
Dearborn 60
Frankfurt am Main 60
Ann Arbor 58
Seattle 57
Milan 56
Woodbridge 54
Marseille 50
Nürnberg 50
Boston 47
Hong Kong 46
Moscow 44
São Paulo 41
Chicago 40
Bremen 37
Cattolica 37
Buffalo 36
Lancaster 36
Boardman 34
Princeton 34
Santa Clara 34
London 30
Montreal 30
Nanchang 29
Council Bluffs 28
Seoul 27
Da Nang 26
Nuremberg 26
Guangzhou 25
Kent 25
Phoenix 25
Redwood City 24
Hyderabad 23
Orem 23
Toronto 23
Atlanta 22
Mexico City 22
Abidjan 21
Brooklyn 21
Denver 21
Cambridge 20
Haiphong 20
Lappeenranta 20
Lawrence 20
Rio de Janeiro 20
Tianjin 20
Amsterdam 19
Brussels 18
Paris 18
Brno 17
Hangzhou 17
San Francisco 17
Turku 17
Johannesburg 16
Leawood 16
Shanghai 16
Vienna 16
Belo Horizonte 15
Naples 15
Poplar 15
Chennai 14
St Louis 14
Stockholm 14
Baghdad 12
Düsseldorf 12
Fremont 12
Manchester 12
Changsha 11
Izmir 11
Washington 11
Wroclaw 11
Florence 10
Kunming 10
New Delhi 10
Norwalk 10
Totale 6.347
Salva come PNG Salva come JPEG
Nome #
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 434
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 346
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 330
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 288
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 271
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 242
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 241
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 230
Correlation between paraproteinaemia and viral reactivation after allo-SCT 216
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 200
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 197
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 193
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 191
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 189
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 185
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 182
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 181
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 180
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 177
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 177
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 176
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 175
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 171
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 171
PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis 160
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 160
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 159
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 158
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 153
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 152
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 151
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 150
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 148
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 147
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 145
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 141
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 140
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 139
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 138
PE_PGRS3 ensures provision of the vital phospholipids cardiolipin and phosphatidylinositols by promoting the interaction between M. tuberculosis and host cells 138
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 137
Digital morphology compared to the optical microscope: A validation study on reporting bone marrow aspirates 130
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 127
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 120
Acute erythroid leukemia with TP53 mutation and BCR/ABL1: challenges in classification and management 117
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes? 117
Unraveling the potential of graphene quantum dots against Mycobacterium tuberculosis infection 116
Evaluation of the Toxic Activity of the Graphene Oxide in the Ex Vivo Model of Human PBMC Infection with Mycobacterium tuberculosis 116
Unlocking Predictive Power: Quantitative Assessment of CAR-T Expansion with Digital Droplet Polymerase Chain Reaction (ddPCR) 112
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 111
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 109
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide :does graft cell content have an impact on main clinical outcomes? 109
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 108
Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor 108
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 108
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients 107
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells 107
The CD4/CD8 ratio of infused CD19-CAR-T is a prognostic factor for efficacy and toxicity 107
Discrepancy between recipient and donor rs4364254 heparanase single nucleotide polymorphism impacts graft-versus-host disease after allogeneic stem cell transplant 107
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 106
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 104
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 102
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 99
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 96
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 90
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T) 89
CD200 and prognosis in chronic lymphocytic leukemia: Conflicting results 89
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 85
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 84
Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML 83
The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting 79
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia 79
Treatment outcomes in elderly patients ≥ 65 years with Large B-Cell Lymphoma (LBCL): a real-world single center experience focusing on potential CD19-CAR-T eligibility in second line 77
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 76
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 74
Cord blood resilience in a patient with relapsing Ph + B lymphoblastic acute leukemia after hematopoietic stem cell transplantation 68
External validation of the accuracy of 'CLLflow score' 67
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation 58
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements 44
Heterogeneous Surface CD79b Expression in Aggressive B-Cell Lymphomas Assessed by Flow Cytometry on Lymph Node Biopsies 39
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 31
CD19 expression on bone marrow hematogones and blasts following anti-CD19 therapy in B-ALL: a descriptive single-center analysis 12
Totale 11.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022619 49 32 7 14 33 20 18 83 33 64 116 150
2022/20231.381 203 193 87 232 93 138 95 96 139 43 45 17
2023/2024738 33 181 28 41 26 100 54 54 10 29 86 96
2024/20252.019 65 61 118 101 169 108 145 92 241 185 405 329
2025/20264.490 582 156 262 504 797 211 886 231 267 286 133 175
2026/2027179 179 0 0 0 0 0 0 0 0 0 0 0
Totale 11.962